Alaunos Therapeutics, Inc.
corporate_fare Company Profile
Alaunos Therapeutics, Inc. (NASDAQ:TCRT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for TCRT at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Alaunos Therapeutics Faces Imminent Liquidity Crisis and Heightened Delisting Risk as Cash Dwindles to $0.35M
- Alaunos Therapeutics Receives Formal Nasdaq Delisting Notice for Equity Deficiency
- Alaunos Therapeutics Discloses Going Concern Doubt, Nasdaq Delisting Risk, and Short Cash Runway
- Alaunos' Oral Obesity Drug ALN1003 Shows Positive Preclinical Proof-of-Concept Data
- Alaunos Therapeutics Reports Positive Preclinical Data for Obesity Drug ALN1003 Amidst Urgent Financing Needs
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$5K
Net Income
-$4.18M
Diluted EPS
-$2.20
Op. Cash Flow
-$2.87M
Free Cash Flow
-$2.97M
Operating Income
-$4.22M
Cash & Equivalents
$1.39M
Debt / Equity
0.00×
Net Margin
-835.20×
Shares Outstanding
2.35M sh
Source: 10-K · filed 2026-04-30 · accession 0001193125-26-197838
show_chartPrice Chart
Loading chart...
feed TCRT - Filings & News (Page 2)
TCRT
May 15, 2026, 5:29 PM EDT
Price at Filing:
$2.47
Real-time Price:
$1.66
Change:
-$0.810 (-33%)
Market Cap:
$6.986M
TCRT
Apr 15, 2026, 4:32 PM EDT
Price at Filing:
$2.89
Real-time Price:
$1.66
Change:
-$1.23 (-43%)
Market Cap:
$6.986M
TCRT
Mar 31, 2026, 4:33 PM EDT
Price at Filing:
$2.86
Real-time Price:
$1.66
Change:
-$1.20 (-42%)
Market Cap:
$6.986M
TCRT
Mar 02, 2026, 9:13 AM EST
Price at Filing:
$3.01
Real-time Price:
$1.66
Change:
-$1.35 (-45%)
Market Cap:
$6.986M
TCRT
Mar 02, 2026, 6:29 AM EST
Price at Filing:
$3.18
Real-time Price:
$1.66
Change:
-$1.52 (-48%)
Market Cap:
$6.986M
TCRT
Feb 24, 2026, 4:56 PM EST
Price at Filing:
$2.85
Real-time Price:
$1.66
Change:
-$1.19 (-42%)
Market Cap:
$6.986M
TCRT
Jan 08, 2026, 8:30 AM EST
Price at Filing:
$3.31
Real-time Price:
$1.66
Change:
-$1.65 (-50%)
Market Cap:
$6.986M